New antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
US4895933A · kind A · utility
0Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 19, 1988 |
| Grant date | Jan 23, 1990 |
| Priority date | — |
| Expiry date | Jan 19, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/886
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
4'-Deoxy-13(S)-dihydro-4'-iododoxorubicin having the formula (II): ##STR1## and pharmaceutically acceptable salts thereof are anti-tumor agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.